医学
癌症
腺癌
临床试验
免疫疗法
入射(几何)
靶向治疗
治疗
肿瘤科
重症监护医学
内科学
疾病
光学
物理
作者
Jarlath Christopher Bolger,Claire L. Donohoe,Maeve Aine Lowery,John Vincent Reynolds
标识
DOI:10.1038/s41416-021-01485-9
摘要
The incidence of oesophageal cancer, in particular adenocarcinoma, has markedly increased over the last four decades with adenocarcinoma becoming the dominant subtype in the West, and mortality rates are high. Nevertheless, overall survival of patients with oesophageal cancer has doubled in the past 20 years, with earlier diagnosis and improved treatments benefiting those patients who can be treated with curative intent. Advances in endotherapy, surgical approaches, and multimodal and other combination therapies have been reported. New vistas have emerged in targeted therapies and immunotherapy, informed by new knowledge in genomics and molecular biology, which present opportunities for personalised cancer therapy and novel clinical trials. This review focuses exclusively on the curative intent treatment pathway, and highlights emerging advances.
科研通智能强力驱动
Strongly Powered by AbleSci AI